Leptin Analog [EPC]

1263 reported adverse events

Drugs of this class: METRELEPTIN

These side effects are most commonly reported by patients taking drugs of the Leptin Analog [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 102
1 WEIGHT DECREASED 93
2 THERAPY CESSATION 92
3 BLOOD GLUCOSE INCREASED 84
4 DRUG INEFFECTIVE 77
5 OFF LABEL USE 68
6 THERAPY INTERRUPTED 66
7 NAUSEA 61
8 BLOOD TRIGLYCERIDES INCREASED 54
9 TREATMENT NONCOMPLIANCE 53
See all common reactions for Leptin Analog [EPC]

Drugs of the Leptin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIET NONCOMPLIANCE 17 0.0462
1 NEUTRALISING ANTIBODIES POSITIVE 19 0.0456
2 INSULIN RESISTANCE 33 0.0158
3 FAT TISSUE DECREASED 6 0.0154
4 PRODUCT USED FOR UNKNOWN INDICATION 11 0.0087
5 PANCREATITIS RELAPSING 7 0.0086
6 BLOOD TRIGLYCERIDES ABNORMAL 7 0.0080
7 HYPERTRIGLYCERIDAEMIA 38 0.0065
8 HYPERPHAGIA 23 0.0058
9 PAPILLARY THYROID CANCER 6 0.0034
See all enriched reactions for Leptin Analog [EPC]